Essential-fatty acid deficiency produces a 52% increase in the rate of phosphatidylethanolamine synthesis in rat liver as calculated from results obtained in vivo [Trewhella & Collins (1973) Biochim. Biophys. Acta 296,[34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50]. This flux change was used to test the possible regulatory roles of ethanolamine kinase and of phosphoethanolamine cytidylyltransferase, which are rate-limiting enzymes of the cytidine pathway for the synthesis of phosphatidylethanolamine [Infante (1977) Biochem. J. 167,[847][848][849]. The results show that essential-fatty acid deficiency produces 50 % and 53 % increases respectively in the specific activity of these enzymes, accounting for the increased rate of phosphatidylethanolamine synthesis produced by this dietary insufficiency. This evidence leads to the conclusion that ethanolamine kinase and phosphoethanolamine cytidylyltransferase have co-ordinated regulatory roles in the flux control of the cytidine pathway, and its sphinganine 1-phosphate lyase branch reaction, for the synthesis of phosphatidylethanolamine.
Essential-fatty acid deficiency produces a 52% increase in the rate of phosphatidylethanolamine synthesis in rat liver as calculated from results obtained in vivo [Trewhella & Collins (1973) Biochim. Biophys. Acta 296, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] . This flux change was used to test the possible regulatory roles of ethanolamine kinase and of phosphoethanolamine cytidylyltransferase, which are rate-limiting enzymes of the cytidine pathway for the synthesis of phosphatidylethanolamine [Infante (1977) Biochem. J. 167, [847] [848] [849] . The results show that essential-fatty acid deficiency produces 50 % and 53 % increases respectively in the specific activity of these enzymes, accounting for the increased rate of phosphatidylethanolamine synthesis produced by this dietary insufficiency. This evidence leads to the conclusion that ethanolamine kinase and phosphoethanolamine cytidylyltransferase have co-ordinated regulatory roles in the flux control of the cytidine pathway, and its sphinganine 1-phosphate lyase branch reaction, for the synthesis of phosphatidylethanolamine.
An enzyme must satisfy two criteria to have a regulatory role in the control of the flux through a metabolic sequence. It must catalyse a rate-limiting reaction, and an observed change in flux through the pathway in vivo must be accounted for by a similar change in the specific activity of the enzyme in question (Infante & Kinsella, 1978a) . Compliance with the latter criterion shows that the enzyme is in fact responding to a regulatory signal. Ethanolamine kinase (MgATP2--ethanolamine phosphotransferase, EC 2.7.1.32) and phosphoethanolamine cytidylyltransferase (MgCTP2-phosphoethanolamine cytidylyltransferase, EC 2.7.7.14) are the only enzymes of the cytidine pathway for the synthesis of phosphatidylethanolamine that comply with the first requirement (Infante, 1977) . However, satisfaction of the second criterion has not been demonstrated.
Essential-fatty acid deficiency increases the biosynthetic flux of some of the phosphatidylcholine species made via the cytidine pathway, i.e. species that contain C16: 1(9) and C18: 1(9) fatty acids (Trewhella & Collins, 1973) . This dietary deficiency has been successfully used to demonstrate a regulatory role for choline kinase (MgATP2--choline phosphotransferase, EC 2.7.1.32) in the control of this pathway (Infante & Kinsella, 1978a) . The essentialfatty acid deficiency also induces a net increase in the synthesis of phosphatidylethanolamines, particularly the species that contain C22 6(4,7,l0,13,16,l9) Vol. 179 fatty acids (Trewhella & Collins, 1973; Pooviah et al., 1976) . Therefore this nutritional perturbation was also used to test the possible regulatory roles of the ethanolamine kinase and of phosphoethanolamine cytidylyltransferase in the control of phosphatidylethanolamine synthesis by the criteria proposed above. The results obtained show that the specific activities of these two rate-limiting enzymes in rat liver are significantly increased by essential-fatty acid deficiency, and account for the increased rate of phosphatidylethanolamine synthesis calculated from results obtained in vivo.
Experimental Procedures Materials
The animals and diets have been described by Infante & Kinsella (1978a) 
Methods
The animals were killed by exsanguination from the abdominal aorta, under light diethyl ether anaesthesia, at a time between 10:00 and 12:00h. The livers were immediately excised, blotted and homogenized in 3vol. of ice-cold 0.25M-sucrose. The high-speed supernatants andthe microsomal fractions were obtained by differential centrifugation and stored as previously described (Infante & Kinsella, 1976a , 1978b (Infante & Kinsella, 1978b) . The radiopurity of 14C-labelled compounds and the recovery of radioactivity in the assays were routinely checked, and were better than 99 %. Protein was determined with the Folin phenol reagent (Lowry et al., 1951) , with crystalline bovine serum albumin as standard. Concentrations of the nucleotide-Mg2+ complexes and of free Mg2+ species were calculated from the appropriate apparent binding constants and the corresponding equilibria equations (Infante & Kinsella, 1976a , 1978a .
Results and Discussion
The essential-fatty acid-deficient animals developed the classical clinical symptoms of this dietary perturbation (Infante & Kinsella, 1978a) .
The specific activity of ethanolamine kinase in the essential-fatty acid-deficient animals increased 50% with respect to the control group ( (Student, 1908; Fisher, 1925) showed that these results were highly significant ( Table 1) .
The increased specific activity of the above enzyme accounts for a 52 % increase in the net rate of phosphatidylethanolamine synthesis calculated from results obtained in vivo from essential-fatty aciddeficient rats (Trewhella & Collins, 1973) . This indicates that these two rate-limiting steps comply with the second requirement proposed before, i..e they accounted for the response observed in vivo (Infante, 1977) . Consequently, these two enzymes must have regulatory roles in the control of the Table 1 . Specific activities of ethanolamine kinase and phosphoethanolamine cytidylyltransferase from livers of controls and essential-fatty acid-deficient rats Results are expressed as means (nmol of product/min per mg of protein) ± S.D. Numbers in parentheses denote the numbers of animals per treatment. Means are significantly higher than the controls at P<0.025 (*), P<0.001 (**) and P<0.0005 (***) by the Student's t test. The operational term 'high-speed supernatant' was preferred to 'cytosol', since the fact that an enzyme can be found in this homogenate fraction is not conclusive evidence for its cytosolic location in vivo. Stoffel & Henning, 1968; Stoffel, 1968 Stoffel, , 1973 Henning & Stoffel, 1969; Shimojo et al., 1976 ). Calculations of rates in vivo of phosphatidylethanolamine synthesis from CDP-ethanolamine indicate that its contribution is of the order of 0.06-0.08,umol/ min per lOg wet wt. of liver (Sundler, 1973) . These rates are of the same order of magnitude as the values obtained by using sphinganine as the labelled precursor, i.e. 0.04,umol/min per lOg wet wt. of liver (Offenbartl et al., 1973) . Therefore, sphinganine 1-phosphate lyase has a significant contribution to the synthesis of phosphoethanolamine. This makes necessary the second regulatory step after this converging branch point so as to control the flux of phosphatidylethanolamine synthesis.
The fact that essential-fatty acid deficiency induces in liver a 3.5-fold increase in the specific activity of choline kinase (Infante & Kinsella, 1978a) , whereas the specific activity of ethanolamine kinase is increased by only 50 %, suggests that these two phosphorylating activities can be independently regulated. This inference is supported by other lines of evidence, suggesting that these two kinase activities may not necessarily be produced by a single identical active site in the same polypeptide chain, in liver and other tissues (Sung & Johnstone, 1967; Weinhold & Rethy, 1974; Broad & Dawson, 1974; Upreti et al., 1976; Infante & Kinsella, 1976b; Brophy et al., 1977) .
